Synergistic NIR-polydopamine nanotherapy for blood–brain barrier crossing and Parkinson's disease intervention
RSC Advances · 2026 · 16 (8) · 6985-6998
DOI: 10.1039/d5ra07719b ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Xueer Xia und 12 weiteren Autor:innen. Beteiligte Einrichtung: Medical Engineering &Engineering Medicine Innovation Center, Hangzhou International Innovation Institute, Beihang University No. 166, Shuanghongqiao …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
This study synthesizes ZnO@PDA as a non-invasive platform for Parkinson's disease treatment. They utilize photothermal effects to open the blood–brain barrier, enable ultrasound-triggered neuronal stimulation, and provide antioxidant therapy.
Autor:innen und Institutionen
- Medical Engineering &Engineering Medicine Innovation Center, Hangzhou International Innovation Institute, Beihang University No. 166, Shuanghongqiao Street, Yuhang District 311115 Hangzhou China sharon@buaa.edu.cn +86-1…
- Department of General Surgery (Colorectal Surgery), Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University Guangzhou 510655 China.
- Department of Neurology, Guangzhou First People's Hospital, The Second Affiliated Hospital of South China University of Technology Guangzhou 510000 China.
- Department of Oncology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University No. 123 Huifu Road West, Yuexiu District Guangzhou 510080 China liujianh80@126.com +86-…
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University Guangzhou 510515 China.
- Department of Gastroenterology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University Guangzhou 510080 China.
ORCID-Profile: Xueer Xia, Yingfeng Tu, Jianhua Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xia, X., Han, J., Lin, M., Tu, Y., Zheng, Y., Liu, B., Chen, Y., Li, X., Zhang, Z., Han, S., Shang, W., Huang, X., & Liu, J. (2026). Synergistic NIR-polydopamine nanotherapy for blood–brain barrier crossing and Parkinson's disease intervention. RSC Advances, 16(8), 6985-6998. https://doi.org/10.1039/d5ra07719b
Vancouver
Xia X, Han J, Lin M, Tu Y, Zheng Y, Liu B, et al. Synergistic NIR-polydopamine nanotherapy for blood–brain barrier crossing and Parkinson's disease intervention. RSC Advances. 2026;16(8):6985-6998. doi:10.1039/d5ra07719b
BibTeX
@article{Xia2026,
author = {Xia, Xueer and Han, Jianbang and Lin, Meiyin and Tu, Yingfeng and Zheng, Yue and Liu, Bin and Chen, Yu and Li, Xin and Zhang, Zirong and Han, Shuai and Shang, Wenting and Huang, Xiazi and Liu, Jianhua},
title = {Synergistic NIR-polydopamine nanotherapy for blood–brain barrier crossing and Parkinson's disease intervention},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {8},
pages = {6985--6998},
doi = {10.1039/d5ra07719b}
}
EUVIMED